Piramal Pharma (BOM:543635) ROCE % : 12.49% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Piramal Pharma's annualized ROCE % for the quarter that ended in Mar. 2024 was 12.49%.

Piramal Pharma ROCE % Historical Data

The historical data trend for Piramal Pharma's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma ROCE % Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

ROCE %

11.21

9.59

2.19

5.81

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial							7.46	0.43	5.35	4.48	12.49

Piramal Pharma ROCE % Calculation

Piramal Pharma's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	6277.8	/	( ( (145225.6 - 38430.5)	+	(153118.1 - 43693) )	/ 2 )
	=	6277.8	/	( (106795.1	+	109425.1)	/ 2 )
	=	6277.8	/	108110.1
	=	5.81 %

Piramal Pharma's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	13668	/	( ( (0 - 0)	+	(153118.1 - 43693) )	/ 1 )
	=	13668	/	( ( 0	+	109425.1 )	/ 1 )
	=	13668	/	109425.1
	=	12.49 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Piramal Pharma (BOM:543635) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Piramal Pharma ROCE % Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (BOM:543635) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (BOM:543635) » Definitions » ROCE %

Traded in Other Exchanges

PPLPHARMA:India

Address

Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (BOM:543635) Headlines

No Headlines